Core Viewpoint - The breakthrough of "transdermal collagen" technology by Furuida Biological Co., under the brand Kemi, marks a significant advancement in the global cosmetics science arena, showcasing China's transition from application follower to principle definer in beauty technology [3][4][10]. Group 1: Event Overview - The 79th Annual Scientific Meeting of the Society of Cosmetic Chemists (SCC) was held in New York on December 16, 2025, celebrating the 80th anniversary of the SCC, which is a historic and influential academic platform in the cosmetics science field [5]. - The conference theme "Science Reimagined" indicates the ongoing transformation within the industry, with a focus on innovative technologies from Chinese enterprises [5][9]. Group 2: Technology Breakthrough - Kemi's report highlighted a 27.5 times increase in the permeability of large molecular collagen, addressing the long-standing challenge of low absorption rates in skincare applications [3][14]. - The technology utilizes a "transdermal engine" that integrates a short peptide sequence capable of penetrating cell membranes into the collagen gene, allowing the collagen to actively enter skin cells [12]. Group 3: Scientific Validation - The efficacy of the transdermal collagen was validated through rigorous scientific methods, including Raman spectroscopy, ensuring that the technology is grounded in real physiological conditions and consumer experiences [4][20]. - Clinical trials demonstrated that after 28 days of using the Kemi Recombined Collagen Anti-Wrinkle Essence, participants experienced a 17.16% reduction in crow's feet and a 23.24% reduction in frown lines, confirming the product's effectiveness [16]. Group 4: Market Impact - Kemi's products have achieved significant market success, with the "transdermal collagen essence" becoming a top-selling item shortly after launch, reflecting consumer demand for scientifically validated anti-aging products [21][23]. - The brand's positioning as a high-end product with a clear technological narrative has resulted in a customer price point significantly above the industry average, breaking the traditional price barriers for domestic brands [21][23]. Group 5: Future Implications - The success of Kemi at the SCC signifies a new phase for Chinese beauty technology, transitioning from product and ingredient output to technology solution output, showcasing the competitive edge of Chinese enterprises in global innovation [23][24]. - The global collagen market is expected to grow at a compound annual growth rate of over 40%, indicating a shift in competition towards a focus on bioactive design, intelligent delivery technology, and scientific efficacy validation [24].

Core Viewpoint - The article discusses the breakthrough of the Chinese anti-aging skincare market, particularly focusing on the innovative "transdermal collagen" technology developed by Kemi, a brand under Furuida Biological Co., which has been recognized as a global pioneer in transdermal collagen skincare products [3][5][6]. Group 1: Market Context and Challenges - The anti-aging skincare market in China has surpassed 100 billion, with collagen becoming a key ingredient in many products, yet consumers face confusion regarding the effectiveness and authenticity of these products [3]. - Issues such as "mislabeling of collagen content" and "difficulty in verifying transdermal effects" have plagued the industry, leading to consumer skepticism [6][9]. - Despite familiarity with collagen, consumers struggle to differentiate between various types, such as collagen peptides and recombinant collagen, complicating their purchasing decisions [6]. Group 2: Kemi's Technological Innovation - Kemi has received certification as the "global pioneer in transdermal collagen skincare products" from Shangpu Consulting, validating its leading position in the industry through a dual verification mechanism of "technical definition + efficacy evidence" [5][7]. - The core of Kemi's innovation lies in embedding transdermal peptide segments into the recombinant type III collagen sequence, allowing for enhanced skin penetration without compromising the collagen's biological activity [9][11]. - Experimental data shows that Kemi's transdermal collagen has a 27.5 times higher penetration rate compared to ordinary recombinant collagen, providing tangible benefits for consumers [11][12]. Group 3: Consumer Reception and Market Performance - Kemi's products, priced around 350 yuan, are positioned as a high-end solution for anti-aging, with strong consumer acceptance reflected in sales performance [14][16]. - The brand achieved significant sales milestones, including a record-breaking GMV of 15.2 million yuan during a live-streaming event, indicating robust market demand [14][16]. - Positive user feedback on social media highlights the effectiveness of Kemi's products, reinforcing the brand's credibility and consumer trust [19][20]. Group 4: Industry Standards and Future Implications - Kemi's technology is not only a product innovation but also a catalyst for industry evolution, establishing new standards for collagen efficacy and consumer trust [21][22]. - The establishment of testing standards and clinical guidelines for skincare products marks a significant step towards addressing market pain points and enhancing the integration of efficacy in skincare and medical aesthetics [22][23]. - Furuida's ongoing commitment to research and development positions it as a leader in the beauty industry, paving the way for a future where technology-driven skincare becomes the norm [23][24].